Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Genetic analysis of human glioblastomas using a genomic microarray system.

Suzuki T, Maruno M, Wada K, Kagawa N, Fujimoto Y, Hashimoto N, Izumoto S, Yoshimine T.

Brain Tumor Pathol. 2004;21(1):27-34.

PMID:
15696966
2.

Detection of gene amplification and deletion in high-grade gliomas using a genome DNA microarray (GenoSensor Array 300).

Sasaki T, Arai H, Beppu T, Ogasawara K.

Brain Tumor Pathol. 2003;20(2):59-63.

PMID:
14756442
3.

A survey of glioblastoma genomic amplifications and deletions.

Rao SK, Edwards J, Joshi AD, Siu IM, Riggins GJ.

J Neurooncol. 2010 Jan;96(2):169-79. doi: 10.1007/s11060-009-9959-4. Epub 2009 Jul 17.

PMID:
19609742
4.

Identification of novel candidate target genes in amplicons of Glioblastoma multiforme tumors detected by expression and CGH microarray profiling.

Ruano Y, Mollejo M, Ribalta T, Fiaño C, Camacho FI, Gómez E, de Lope AR, Hernández-Moneo JL, Martínez P, Meléndez B.

Mol Cancer. 2006 Sep 26;5:39.

5.

Genetic analyses for predictors of radiation response in glioblastoma.

Shih HA, Betensky RA, Dorfman MV, Louis DN, Loeffler JS, Batchelor TT.

Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):704-10. Epub 2005 Jun 22.

PMID:
15978739
6.

Whole-genome analysis of human astrocytic tumors by comparative genomic hybridization.

Maruno M, Ninomiya H, Ghulam Muhammad AK, Hirata M, Kato A, Yoshimine T.

Brain Tumor Pathol. 2000;17(1):21-7.

PMID:
10982006
7.

Detrended fluctuation analysis of genome-wide copy number profiles of glioblastomas using array-based comparative genomic hybridization.

Nakahara Y, Shiraishi T, Okamoto H, Mineta T, Oishi T, Sasaki K, Tabuchi K.

Neuro Oncol. 2004 Oct;6(4):281-9.

8.

Identification of oligodendroglioma specific chromosomal copy number changes in the glioblastoma MI-4 cell line by array-CGH and FISH analyses.

Magnani I, Moroni RF, Roversi G, Beghini A, Pfundt R, Schoenmakers EF, Larizza L.

Cancer Genet Cytogenet. 2005 Sep;161(2):140-5. Erratum in: Cancer Genet Cytogenet. 2005 Nov;163(1):99. Ramona, Ramona Frida [corrected to Moroni, Ramona Frida].

PMID:
16102584
9.

Intratumoral patterns of genomic imbalance in glioblastomas.

Nobusawa S, Lachuer J, Wierinckx A, Kim YH, Huang J, Legras C, Kleihues P, Ohgaki H.

Brain Pathol. 2010 Sep;20(5):936-44. doi: 10.1111/j.1750-3639.2010.00395.x. Epub 2010 Mar 18.

PMID:
20406234
10.

High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray.

Yin D, Ogawa S, Kawamata N, Tunici P, Finocchiaro G, Eoli M, Ruckert C, Huynh T, Liu G, Kato M, Sanada M, Jauch A, Dugas M, Black KL, Koeffler HP.

Mol Cancer Res. 2009 May;7(5):665-77. doi: 10.1158/1541-7786.MCR-08-0270. Epub 2009 May 12.

11.

Comprehensive analysis of genomic alterations in gliosarcoma and its two tissue components.

Actor B, Cobbers JM, Büschges R, Wolter M, Knobbe CB, Lichter P, Reifenberger G, Weber RG.

Genes Chromosomes Cancer. 2002 Aug;34(4):416-27.

PMID:
12112531
12.

Genomic alterations in low-grade, anaplastic astrocytomas and glioblastomas.

Arslantas A, Artan S, Oner U, Müslümanoglu MH, Ozdemir M, Durmaz R, Arslantas D, Vural M, Cosan E, Atasoy MA.

Pathol Oncol Res. 2007;13(1):39-46. Epub 2007 Mar 27.

13.

High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors: four cases of homozygous deletions of the CDKN2A gene.

Carén H, Erichsen J, Olsson L, Enerbäck C, Sjöberg RM, Abrahamsson J, Kogner P, Martinsson T.

BMC Genomics. 2008 Jul 29;9:353. doi: 10.1186/1471-2164-9-353.

14.

Correlation among pathology, genotype, and patient outcomes in glioblastoma.

Homma T, Fukushima T, Vaccarella S, Yonekawa Y, Di Patre PL, Franceschi S, Ohgaki H.

J Neuropathol Exp Neurol. 2006 Sep;65(9):846-54.

15.

Detailed characterization of alterations of chromosomes 7, 9, and 10 in glioblastomas as assessed by single-nucleotide polymorphism arrays.

Crespo I, Vital AL, Nieto AB, Rebelo O, Tão H, Lopes MC, Oliveira CR, French PJ, Orfao A, Tabernero MD.

J Mol Diagn. 2011 Nov;13(6):634-47. doi: 10.1016/j.jmoldx.2011.06.003. Epub 2011 Aug 30.

16.
17.
18.

Chromosomal and genetic aberrations differ with meningioma subtype.

Wada K, Maruno M, Suzuki T, Kagawa N, Hashiba T, Fujimoto Y, Hashimoto N, Izumoto S, Yoshimine T.

Brain Tumor Pathol. 2004;21(3):127-33.

PMID:
15696974
19.

Amplification of genes encoding KIT, PDGFRalpha and VEGFR2 receptor tyrosine kinases is frequent in glioblastoma multiforme.

Joensuu H, Puputti M, Sihto H, Tynninen O, Nupponen NN.

J Pathol. 2005 Oct;207(2):224-31.

PMID:
16021678
20.

Oligonucleotide DNA chips are useful adjuncts in epigenetic studies of glioblastomas.

Kim B, Kim H, Song BJ, Cha SH, Lee MO, Park SH.

Neuropathology. 2006 Oct;26(5):409-16.

PMID:
17080717
Items per page

Supplemental Content

Write to the Help Desk